Herbert R. Henney

890 total citations
30 papers, 657 citations indexed

About

Herbert R. Henney is a scholar working on Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health. According to data from OpenAlex, Herbert R. Henney has authored 30 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 10 papers in Pediatrics, Perinatology and Child Health and 10 papers in Psychiatry and Mental health. Recurrent topics in Herbert R. Henney's work include Multiple Sclerosis Research Studies (15 papers), Epilepsy research and treatment (9 papers) and Pharmaceutical studies and practices (8 papers). Herbert R. Henney is often cited by papers focused on Multiple Sclerosis Research Studies (15 papers), Epilepsy research and treatment (9 papers) and Pharmaceutical studies and practices (8 papers). Herbert R. Henney collaborates with scholars based in United States, Netherlands and United Kingdom. Herbert R. Henney's co-authors include Andrew R. Blight, Nino Stocchetti, Gordon Murray, Andrew I.R. Maas, Valérie Legrand, Nadim Kassem, Nachshon Knoller, Timothy R. Vollmer, Timothy Vollmer and Adrián L. Rabinowicz and has published in prestigious journals such as Neurology, Stroke and The Lancet Neurology.

In The Last Decade

Herbert R. Henney

28 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Herbert R. Henney United States 14 284 200 127 113 96 30 657
Jimmi Hatton United States 13 263 0.9× 56 0.3× 211 1.7× 41 0.4× 79 0.8× 36 711
Sherry R. Brunnemann United States 16 68 0.2× 451 2.3× 84 0.7× 96 0.8× 73 0.8× 26 743
Andreas Alt Germany 19 51 0.2× 465 2.3× 334 2.6× 89 0.8× 92 1.0× 37 1.0k
Anders Dejgård Denmark 8 246 0.9× 44 0.2× 107 0.8× 169 1.5× 68 0.7× 13 916
Y. Hatano Japan 14 64 0.2× 82 0.4× 129 1.0× 53 0.5× 183 1.9× 35 714
Guomin Xiao China 6 280 1.0× 33 0.2× 219 1.7× 18 0.2× 73 0.8× 7 589
William G. Brose United States 15 64 0.2× 55 0.3× 120 0.9× 112 1.0× 83 0.9× 24 790
Kyung Hwa Kwak South Korea 16 74 0.3× 111 0.6× 61 0.5× 57 0.5× 45 0.5× 69 721
Michael S. Leong United States 9 72 0.3× 65 0.3× 55 0.4× 106 0.9× 21 0.2× 26 514
Michael A. Ueberall Germany 12 72 0.3× 68 0.3× 24 0.2× 134 1.2× 38 0.4× 28 588

Countries citing papers authored by Herbert R. Henney

Since Specialization
Citations

This map shows the geographic impact of Herbert R. Henney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert R. Henney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert R. Henney more than expected).

Fields of papers citing papers by Herbert R. Henney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert R. Henney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert R. Henney. The network helps show where Herbert R. Henney may publish in the future.

Co-authorship network of co-authors of Herbert R. Henney

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert R. Henney. A scholar is included among the top collaborators of Herbert R. Henney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert R. Henney. Herbert R. Henney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Safirstein, Beth, et al.. (2020). Pharmacokinetics of Inhaled Levodopa Administered With Oral Carbidopa in the Fed State in Patients With Parkinson's Disease. Clinical Therapeutics. 42(6). 1034–1046. 15 indexed citations
2.
Kantor, Daniel, et al.. (2015). Assessment of confirmed urinary tract infection in patients treated with dalfampridine for multiple sclerosis. Postgraduate Medicine. 127(2). 218–222. 7 indexed citations
3.
Fjeldstad, Cecilie, et al.. (2015). Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis. International Journal of MS Care. 17(6). 275–283. 5 indexed citations
4.
Henney, Herbert R., et al.. (2014). Assessment of pharmacokinetics and tolerability of intranasal diazepam relative to rectal gel in healthy adults. Epilepsy Research. 108(7). 1204–1211. 26 indexed citations
5.
Applebee, Angela, François Béthoux, Myla Goldman, et al.. (2014). Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis. International Journal of MS Care. 17(3). 138–145. 14 indexed citations
6.
Jara, Michele, et al.. (2014). Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis. Therapeutics and Clinical Risk Management. 11. 1–1. 4 indexed citations
7.
8.
Samara, Emil, Peter Winkle, P. Gómez Pardo, et al.. (2013). Pharmacokinetics of dalfampridine extended release 7.5‐mg tablets in healthy subjects and individuals with mild and moderate renal impairment: An open‐label study. The Journal of Clinical Pharmacology. 54(1). 53–60. 6 indexed citations
9.
10.
11.
12.
Smith, William B., Suzanne K. Swan, Thomas Marbury, & Herbert R. Henney. (2009). Single‐Dose Pharmacokinetics of Sustained‐Release Fampridine (Fampridine‐SR) in Healthy Volunteers and Adults With Renal Impairment. The Journal of Clinical Pharmacology. 50(2). 151–159. 34 indexed citations
13.
Vollmer, Timothy, Andrew R. Blight, & Herbert R. Henney. (2009). Steady-state pharmacokinetics and tolerability of orally administered fampridine sustained-Release 10-mg tablets in patients with multiple sclerosis: A 2-week, open-label, follow-up study. Clinical Therapeutics. 31(10). 2215–2223. 34 indexed citations
14.
Henney, Herbert R. & Michael Chez. (2009). Pediatric Safety of Tizanidine. Pediatric Drugs. 11(6). 397–406. 17 indexed citations
15.
Henney, Herbert R., et al.. (2008). A clinically relevant review of tizanidine hydrochloride dose relationships to pharmacokinetics, drug safety and effectiveness in healthy subjects and patients. International Journal of Clinical Practice. 62(2). 314–324. 28 indexed citations
16.
17.
18.
Shah, Jaymin, et al.. (2006). Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers. Clinical Therapeutics. 28(9). 1308–1317. 18 indexed citations
19.
Maas, Andrew I.R., Gordon Murray, Herbert R. Henney, et al.. (2005). Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. The Lancet Neurology. 5(1). 38–45. 218 indexed citations
20.
Henney, Herbert R., et al.. (1984). Knowledge of nurses and respiratory therapists about using canister nebulizers. American Journal of Health-System Pharmacy. 41(11). 2403–2405.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jimmi Hatton Breakdown of academic impact, for papers by Sherry R. Brunnemann Breakdown of academic impact, for papers by Andreas Alt Breakdown of academic impact, for papers by Anders Dejgård Breakdown of academic impact, for papers by Y. Hatano Breakdown of academic impact, for papers by Guomin Xiao Breakdown of academic impact, for papers by William G. Brose Breakdown of academic impact, for papers by Kyung Hwa Kwak Breakdown of academic impact, for papers by Michael S. Leong Breakdown of academic impact, for papers by Michael A. Ueberall
Rankless by CCL
2026